Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
Go back to Amgen Presents Detailed Data Comparing Etelcalcetide With Cinacalcet In Patients With Secondary Hyperparathyroidism Receiving Hemodialysis| Amgen Inc (NASDAQ: AMGN) | Delayed: 344.11 +6.51 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.60 | 52 Week High | $176.85 | |||
| Open | $337.65 | 52 Week Low | $133.64 | |||
| Day High | $344.98 | P/E | 51.82 | |||
| Day Low | $341.00 | EPS | $6.64 | |||
| Volume | 617,606 | |||||

